Literature DB >> 23814765

White willow bark induced acute respiratory distress syndrome.

Narat Srivali1, Wisit Cheungpasitporn, Daych Chongnarungsin, Lee C Edmonds.   

Abstract

Entities:  

Year:  2013        PMID: 23814765      PMCID: PMC3690791          DOI: 10.4103/1947-2714.112483

Source DB:  PubMed          Journal:  N Am J Med Sci        ISSN: 1947-2714


× No keyword cloud information.
Dear Editor, A 61-year-old female with the past medical history of hypertension and osteoarthritis presented to Emergency Department with sudden onset of shortness of breath and non-productive cough 30 min, after taking white willow bark supplement. The patient denied any history of the drug or supplement allergy. Pulse oximetry demonstrated oxygen desaturation; SpO2 of 75% on ambient air and 94% on nasal cannula with the flow of oxygen 20 L/min. Arterial blood gas although on FiO2 of 100% showed severe hypoxemia with the high A-a gradient, metabolic acidosis with respiratory compensation (pH 7.28, PCO2 36 mmHg, PaO2 75 mmHg, and HCO3 19 mmol/L). Blood tests demonstrated evidence of wide anion gap (AG) metabolic acidosis (AG 14 mmol/L) from lactic acidosis (lactic acid 4.9 mmol/L) with the normal gap metabolic acidosis (∆AG/∆Bicarb = 0.4) and the patient had no osmolal gap. Furthermore, serum ketone and salicylate levels were undetectable and her chest X-ray showed bilateral interstitial infiltrates [Figure 1]. Transthoracic echocardiogram revealed normal systolic and diastolic function. The diagnosis of acute hypoxic respiratory failure secondary to severe acute respiratory distress syndrome (ARDS) from reaction to white willow bark was made; the PaO2/FiO2 of 75 mmHg. The patient was promptly started on intravenous venous methylprednisolone and oral antihistamines including diphenhydramine and ranitidine. The patient responded well with our treatment and her oxygen requirement gradually improved from 94% on FiO2 of 100% to 95% on room air. Lactic acidosis also subsided after maintaining adequate oxygenation.
Figure 1

Chest X-ray demonstrated bilateral interstitial infiltrates

Chest X-ray demonstrated bilateral interstitial infiltrates The use of white willow bark supplement was first reported back to the time of Hippocrates (400 BC) when patients were advised to chew on the bark for pain relief and fever reduction. Willow bark is also included in weight-loss products.[1] There have been a remarkably small number of reported cases of adverse reactions to willow bark extract. These adverse drug reactions are usually mild (maculopapular rashes). White willow bark induced anaphylaxis is rare; however, a few cases have been reported.[23] To our knowledge, this is the first report of white willow bark induced ARDS. People who are allergic or sensitive to salicylates (such as aspirin) should not use willow bark.
  3 in total

1.  Thermogenic synergism between ephedrine and caffeine in healthy volunteers: a double-blind, placebo-controlled study.

Authors:  A Astrup; S Toubro; S Cannon; P Hein; J Madsen
Journal:  Metabolism       Date:  1991-03       Impact factor: 8.694

2.  Anaphylaxis induced by ingestion of a pollen compound.

Authors:  T Chivato; F Juan; A Montoro; R Laguna
Journal:  J Investig Allergol Clin Immunol       Date:  1996 May-Jun       Impact factor: 4.333

3.  Anaphylactic reaction to a dietary supplement containing willow bark.

Authors:  Joseph I Boullata; Patrick J McDonnell; Cynthia D Oliva
Journal:  Ann Pharmacother       Date:  2003-06       Impact factor: 3.154

  3 in total
  1 in total

1.  Acute pancreatitis in the use of canagliflozin: A rare side-effect of the novel therapy for type 2 diabetes mellitus.

Authors:  Narat Srivali; Charat Thongprayoon; Wisit Cheungpasitporn; Patompong Ungprasert
Journal:  J Basic Clin Pharm       Date:  2015-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.